Search research articles
Contact Us
Filters
Showing results (71-80 of 274) with videos related to
Page
of 28
Sort By:
Drugs in Context
|
April 23, 2021
Selective IL-13 inhibitors for the treatment of atopic dermatitis
Francisca Gonçalves, Egídio Freitas, Tiago Torres
Pharmaceutics
|
July 27, 2024
New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors
João Vilaça, Orhan Yilmaz, Tiago Torres
Pharmaceutics
|
January 23, 2024
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents
Anastasia Drakos, Tiago Torres, Ronald Vender
Drugs
|
December 19, 2023
Spesolimab for the Treatment of Generalized Pustular Psoriasis
Diana Bernardo, Diamant Thaçi, Tiago Torres
Acta Dermato-Venereologica
|
November 22, 2011
Dusky red swelling of the penis in association with fever and diarrhoea: a quiz. Metastatic Crohn's disease of the penis associated with enteric Crohn's disease
Andrea Saggini, Andrea Chiricozzi, Tiago Torres
Drugs
|
October 8, 2021
Bimekizumab for the Treatment of Psoriasis
Egídio Freitas, Andrew Blauvelt, Tiago Torres
Acta Medica Portuguesa
|
February 10, 2020
[Neurofibromatosis Type 1: Exuberant Cutaneous Involvement]
Sandra Ferreira, Manuela Selores, Tiago Torres
Acta Medica Portuguesa
|
January 7, 2014
Impact of biosimilars in psoriasis treatment
Tiago Torres, Paulo Filipe, Manuela Selores
Drugs in Context
|
October 2, 2023
Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
Sofia Faria, Egídio Freitas, Tiago Torres
The Journal of International Medical Research
|
June 13, 2023
Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?
Dea Metko, Tiago Torres, Ronald Vender
Page
of 28
Search research articles
Search
Showing results (71-80 of 274) with videos related to
Sort By:
Page
of 28
Drugs in Context
|
April 23, 2021
Selective IL-13 inhibitors for the treatment of atopic dermatitis
Francisca Gonçalves, Egídio Freitas, Tiago Torres
Pharmaceutics
|
July 27, 2024
New and Emerging Treatments for Generalized Pustular Psoriasis: Focus on IL-36 Receptor Inhibitors
João Vilaça, Orhan Yilmaz, Tiago Torres
Pharmaceutics
|
January 23, 2024
Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents
Anastasia Drakos, Tiago Torres, Ronald Vender
Drugs
|
December 19, 2023
Spesolimab for the Treatment of Generalized Pustular Psoriasis
Diana Bernardo, Diamant Thaçi, Tiago Torres
Acta Dermato-Venereologica
|
November 22, 2011
Dusky red swelling of the penis in association with fever and diarrhoea: a quiz. Metastatic Crohn's disease of the penis associated with enteric Crohn's disease
Andrea Saggini, Andrea Chiricozzi, Tiago Torres
Drugs
|
October 8, 2021
Bimekizumab for the Treatment of Psoriasis
Egídio Freitas, Andrew Blauvelt, Tiago Torres
Acta Medica Portuguesa
|
February 10, 2020
[Neurofibromatosis Type 1: Exuberant Cutaneous Involvement]
Sandra Ferreira, Manuela Selores, Tiago Torres
Acta Medica Portuguesa
|
January 7, 2014
Impact of biosimilars in psoriasis treatment
Tiago Torres, Paulo Filipe, Manuela Selores
Drugs in Context
|
October 2, 2023
Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date
Sofia Faria, Egídio Freitas, Tiago Torres
The Journal of International Medical Research
|
June 13, 2023
Viewpoint about biologic agents for psoriasis: are they immunosuppressants or immunomodulators?
Dea Metko, Tiago Torres, Ronald Vender
Page
of 28